Literature DB >> 15815888

[Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

R-M Szeimies1, S Karrer, H Bäcker.   

Abstract

There has been worldwide a significant rise in the incidence of epithelial skin tumors and their precursors in the past years with an increased number of younger patients affected. The risk factors are identified. The choice of the appropriate treatment for each individual is crucial. Major consideration include high cure rate, low long-term recurrence rate and few side effects. In the following article different therapeutic approaches for actinic keratoses, Bowen's disease, basal cell carcinoma and squamous cell carcinoma are presented and analysed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815888     DOI: 10.1007/s00105-005-0950-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  46 in total

Review 1.  Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source.

Authors:  S Varma; H Wilson; H A Kurwa; B Gambles; C Charman; A D Pearse; D Taylor; A V Anstey
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

2.  Bowen's disease--a retrospective review of clinical management.

Authors:  H K Bell; L E Rhodes
Journal:  Clin Exp Dermatol       Date:  1999-07       Impact factor: 3.470

3.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.

Authors:  John Geisse; Ivor Caro; Jane Lindholm; Loren Golitz; Patti Stampone; Mary Owens
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

4.  A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses.

Authors:  H A Kurwa; S A Yong-Gee; P T Seed; A C Markey; R J Barlow
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

5.  Imiquimod 5% cream in the treatment of Bowen's disease.

Authors:  A Mackenzie-Wood; S Kossard; J de Launey; B Wilkinson; M L Owens
Journal:  J Am Acad Dermatol       Date:  2001-03       Impact factor: 11.527

6.  Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.

Authors:  J E Wolf; J R Taylor; E Tschen; S Kang
Journal:  Int J Dermatol       Date:  2001-11       Impact factor: 2.736

7.  [Radiotherapy for basal cell carcinoma. Local control and cosmetic outcome].

Authors:  M H Seegenschmiedt; S Oberste-Beulmann; E Lang; B Lang; F Guntrum; T Olschewski
Journal:  Strahlenther Onkol       Date:  2001-05       Impact factor: 3.621

8.  A prospective study of the use of cryosurgery for the treatment of actinic keratoses.

Authors:  Keng-Ee Thai; Peter Fergin; Michael Freeman; Carl Vinciullo; David Francis; Lynda Spelman; Dedee Murrell; Chris Anderson; Warren Weightman; Catherine Reid; Alan Watson; Peter Foley
Journal:  Int J Dermatol       Date:  2004-09       Impact factor: 2.736

9.  Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Dermatol Surg Oncol       Date:  1989-04

10.  Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study.

Authors:  F Reymann
Journal:  Dermatologica       Date:  1979
View more
  5 in total

1.  [Precancerous tumors and carcinomas in situ of the skin].

Authors:  D Krüger-Corcoran; S Vandersee; E Stockfleth
Journal:  Internist (Berl)       Date:  2013-06       Impact factor: 0.743

Review 2.  [Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options].

Authors:  T Strunk; R-M Szeimies
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

Review 3.  [Actinic keratoses].

Authors:  T Hommel; R-M Szeimies
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

Review 4.  [Skin tumours of the facial area].

Authors:  M Braun-Falco
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

Review 5.  [Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin].

Authors:  C Kunte; B Konz
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.